Globalization in the Healthcare Industry: Drivers, Risks, and Adaptation.

Area of Science:

• Healthcare Management
• Global Health Policy
• Health Systems Research

Background:

• Globalization increases healthcare interconnections, fostering innovation while introducing systemic vulnerabilities.
• The COVID-19 pandemic underscored risks in global supply chains and highlighted benefits of international cooperation.
• Digital health, AI, and data governance are key areas of impact, presenting both opportunities and challenges.

Purpose of the Study:

• To review and synthesize the main channels through which globalization impacts the healthcare industry.
• To analyze the dual nature of globalization: its role in accelerating innovation and expanding access versus creating new vulnerabilities.
• To examine the implications of digitalization, AI, and data governance in global healthcare.

Main Methods:

• Conceptual synthesis of existing literature and research.
• Review of key impact channels including pharmaceuticals, supply chains, service mobility, human resources, digitalization, ethics, and sustainability.
• Analysis of case studies and implications from global events like the COVID-19 pandemic.

Main Results:

• Globalization drives innovation in pharmaceuticals, clinical development, and digital health solutions like AI and telemedicine.
• Significant vulnerabilities are identified in global supply chains, human resource mobility, and data security.
• International guidelines promote standardization, but heterogeneous local capacities lead to varied implementation effects.

Conclusions:

• Globalization presents a dual impact on healthcare, enhancing innovation and access while simultaneously increasing systemic risks.
• Addressing vulnerabilities in supply chains, data governance, and cybersecurity is crucial for resilient healthcare systems.
• The healthcare industry faces complex adaptive pressures from globalization, digitalization, and climate change, necessitating strategic policy and management.